-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster III

Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Lucas Kühne, MD1*, Paul Knoebl, MD2*, Kathrin Eller, MD3*, Ingrid Pabinger, MD4, Paul T. Brinkkoetter, MD5* and Linus A. Voelker5*

1University Hospital Cologne, Cologne, Germany
2University of Vienna, Vienna, Austria
3Medizinische Universität Graz, Graz, AUT
4Medical University of Vienna, Vienna, Austria
5Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Shreya Agarwal, MD1*, Senthil Sukumar, MD, MSc2, Camila Masias, MD, MPH3 and Spero Cataland, MD4

1Benioff Children's Hospital/University of California San Francisco, San Francisco, CA
2Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
3Miami Cancer Institute, Miami, FL
4Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH

Marissa Schraner, PhD1,2, Erika Tarasco, PhD2,3*, Odile Stalder, MSc4*, Kenneth D. Friedman, MD5, James N. George, MD6, Ingrid Hrachovinova, PhD7*, Paul N. Knöbl, MD8*, Masanori Matsumoto9, Reinhard Schneppenheim, MD, PhD10, Anne-Sophie Von Krogh, MD11,12*, Zuzana Cermakova, MD13*, Magdalena Górska-Kosicka, MD14*, Kazuya Sakai, MD, PhD9*, György Sinkovits, MD, PhD15*, Yasmine El Chazli, MD16*, Carlo R. Largiadèr, PhD17*, Oleg Pikovsky, MD18, Jerzy Windyga, MD, PhD14, Bernhard Lämmle, MD19* and Johanna A. Kremer Hovinga, MD2,3

1Department for BioMedical Research (DBMR), University of Bern, 3008, Switzerland
2Department of Hematology and Central Hematology Laboratory, Bern University Hospital, Bern, Switzerland
3Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
4CTU Bern, University of Bern, Bern, Switzerland
5Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
6Department of Biostatistics & Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK
7NRL for Hemostasis, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
8Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria
9Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan
10Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11Department of Hematology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
12Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
13Blood Center, University Hospital Ostrava, Ostrava, Czech Republic
14Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
15Department of Internal Medicine and Hematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest, Hungary
16Hematology/Oncology Unit, Department of Pediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt
17University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland
18Transfusion Medicine Institute, Soroka University Medical Center, Beer-Sheva, Israel
19Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany

Ishan J Tatake, MD1,2, Shelby C Wilkinson, BS, BA1, Kristen N Ruby, DO, MPH1,3*, Julia N Collins3*, Walter Dzik, MD1,3,4, Lynne Uhl, MD1,5, Richard M Kaufman, MD1,6, Brian J Carney, MD1,7, Robert Makar, MD, PhD1,3 and Pavan K Bendapudi, MD1,3,8,9,10

1Harvard Medical School, Boston, MA
2Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Brookline, MA
3Blood Transfusion Service, Department of Pathology, Massachusetts General Hospital, Boston, MA
4Division of Hematology, Department of Medicine, Massachusetts General Hospital, Boston, MA
5Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA
6Department of Pathology, Brigham and Women's Hospital, Boston, MA
7Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA
8Division of Thrombosis and Hemostasis, Beth Israel Deaconess Medical Center, Boston, MA
9Division of Hematology, Department of Medicine, Massachusetts General Hospital, Cambridge, MA
10Center for the Development of Therapeutics, The Broad Institute of MIT and Harvard, Cambridge, MA

Chan Meng, M.D.1*, Konstantine Halkidis, M.D., Ph.D.1*, Szumam Liu, Ph.D.2 and X. Long Zheng, MD, PhD2,3

1Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS
3Institute for Reproductive Medicine and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS

PAUL Coppo1*, Marie Scully, MD2, Johanna A. Kremer Hovinga, MD3, Maria Jose Aragon4*, Parth Patwari, MD, PhD5*, Linda T. Wang5*, Bjorn Mellgard5, Olulade Ayodele5* and Ragy Saad5*

1APHP - Hôpital St Antoine, Paris, France
2University College London, London, ENG, United Kingdom
3Department of Hematology and Central Hematology Laboratory, Bern University Hospital, Bern, Switzerland
4HCD Economics, Daresbury, United Kingdom
5Takeda Development Center Americas, Inc., Cambridge, MA

Vamsee Torri, MD1,2, Mark Friedman, DO3,4*, Ilan Shapira, MD5, Amit A. Patel, MD1,6,7,8*, Joseph Yoe, MD1*, Vijay P. Shah, MD9, Tahir Mirzoyev, MD1*, Maria Machuca, RN5* and Mala Varma, MD1

1Hematology-Oncology, Mount Sinai West and Mount Sinai Morningside, New York, NY
2St. Joseph's Hospital and Medical Center, Phoenix, AZ
3Pathology/Blood Bank, Mount Sinai West and Mount Sinai Morningside, New York, NY
4NYU Langone Hospital-Long Island, Mineola, NY
5Hematology-Oncology, Mount Sinai Beth Israel, New York, NY
6RWJ Barnabas Health - Jersey City Medical Center, Jersey City, NJ
7St. George's University School of Medicine, St. George's, Grenada
8New York Institute of Technology, New York, NY
9Pathology/Blood Bank, Mount Sinai Beth Israel, New York, NY

Amaya Llorente, MD1, Rodrigo Figueroa-Méndez, MD2*, Gabriela Hernandez-Molina, MD3* and Alfonso Orozco Collazo, MD1*

1Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
2Intensive Care Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
3Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Camila Masias, MD, MPH1, Meera Sridharan, MD PhD2, Richard Burwick3*, Frank Akwaa, MD4, Radhika Gangaraju, MD5, Anuja Java6*, Marshall Mazepa, MD7, Senthil Sukumar, MD, MSc8 and Ana G. Antun, MD9

1Miami Cancer Institute, Miami, FL
2Mayo Clinic, Rochester
3Maternal Fetal Medicine, Cedars Sinai, Playa Vista, CA
4University of Rochester Medical Center, Rochester, NY
5University Of Alabama, Birmingham, AL
6Washington University School of Medicine in St Louis, St Louis, MO
7Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
8Section of Hematology-Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
9Emory University, Atlanta

*signifies non-member of ASH